Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga March 12, 2014 at 08:15 AM EDT OXiGENE (NASDAQ: OXGN) soared 136.78% to $5.73 in the pre-market trading following Tuesday's positive ZYBRESTAT trial announcement. ... Read More >> Related Stocks: Central EUR Med A Paymentus Holdings Inc Cl A Qiwi Plc ADR